Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Finepoint Capital

Latest statistics and disclosures from Finepoint Capital's latest quarterly 13F-HR filing:

Top 5 stock holdings are MLTX, FOLD, SRPT, PRTA, GLPG, and represent 43.49% of Finepoint Capital's stock portfolio.
Added to shares of these 10 stocks: RVMD (+$12M), SRPT, ASND, FOLD, CYTK, ARVN, GLPG, MLTX, CERE, PRTA.
Started 2 new stock positions in RVMD, CLDI.
Reduced shares in these 10 stocks: APLS (-$22M), SAGE (-$17M), CRNX (-$14M), CLVT (-$12M), BHC (-$9.3M), ACAD (-$6.1M), SWTX, Afternext Healthtech Acquisi, Conyers Park Iii Acqsitn Cor, Bilander Acquisition Corp A.
Sold out of its positions in APLS, BHC, Bilander Acquisition Corp A, Conyers Park Iii Acqsitn Cor, CRNX, SAGE, Afternext Healthtech Acquisi, CLVT, Corsair Partnering Corp A.
Finepoint Capital was a net seller of stock by $-49M.
Finepoint Capital has $201M in assets under management (AUM), dropping by -30.54%.
Central Index Key (CIK): 0001608126

Tip: Access up to 7 years of quarterly data

Positions held by Finepoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Finepoint Capital

Finepoint Capital holds 30 positions in its portfolio as reported in the September 2023 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Moonlake Immunotherapeutics Class A Ord (MLTX)	9.4	$19M	+9%	331k	57.00	View chart
Amicus Therapeutics (FOLD)	9.0	$18M	+12%	1.5M	12.16	View chart
Sarepta Therapeutics (SRPT)	8.8	$18M	+15%	145k	121.22	View chart
Prothena Corp SHS (PRTA)	8.4	$17M	+10%	349k	48.25	View chart
Galapagos Nv Spon Adr (GLPG)	7.9	$16M	+12%	459k	34.55	View chart
Ascendis Pharma A/s Sponsored Adr (ASND)	7.6	$15M	+17%	164k	93.64	View chart
Springworks Therapeutics (SWTX)	6.4	$13M	-8%	557k	23.12	View chart
Cytokinetics Com New (CYTK)	6.3	$13M	+16%	432k	29.46	View chart
Cerevel Therapeutics Hldng I (CERE)	6.1	$12M	+14%	563k	21.83	View chart
Revolution Medicines (RVMD)	5.9	$12M	NEW	427k	27.68	View chart
ACADIA Pharmaceuticals (ACAD)	5.8	$12M	-34%	557k	20.84	View chart
Arvinas Ord (ARVN)	4.9	$9.9M	+22%	505k	19.64	View chart
Travere Therapeutics (TVTX)	4.0	$8.0M	+17%	896k	8.94	View chart
Morphic Hldg (MORF)	3.7	$7.5M	+13%	325k	22.91	View chart
Relay Therapeutics (RLAY)	3.6	$7.3M	+24%	871k	8.41	View chart
Solid Biosciences Com New (SLDB)	1.2	$2.4M		961k	2.52	View chart
Calidi Biotherapeutics Com New (CLDI)	0.2	$416k	NEW	125k	3.33	View chart
Ares Acquisition Corp *w Exp 02/02/202	0.2	$334k		505k	0.66	View chart
Bridgetown Holdings *w Exp 09/30/202	0.2	$304k		895k	0.34	View chart
Churchill Capital Corp Vii *w Exp 02/29/202 (CVIIW)	0.1	$169k		548k	0.31	View chart
Calidi Biotherapeutics *w Exp 03/14/202 (CLDI.WS)	0.1	$144k		655k	0.22	View chart
Compass Digital Acquisition Corp *w Exp 09/29/202 (CDAQW)	0.1	$101k		460k	0.22	View chart
Churchill Capital Corp Vi *w Exp 02/17/202	0.0	$86k		540k	0.16	View chart
Ross Acquisition Corp Ii *w Exp 02/01/202	0.0	$49k		440k	0.11	View chart
Concord Acquisition Corp Ii *w Exp 99/99/999 (CNDA.WS)	0.0	$43k		408k	0.10	View chart
Swiftmerge Acquisition Corp *w Exp 12/13/202 (IVCPW)	0.0	$35k		490k	0.07	View chart
Ys Biopharma *w Exp 03/15/202 (YSBPW)	0.0	$17k		490k	0.04	View chart
Marblegate Acquisition Corp *w Exp 08/31/202 (GATEW)	0.0	$14k		735k	0.02	View chart
Churchill Capital Corp V *w Exp 10/29/202	0.0	$0		612k	0.00	View chart
Home Plate Acquisition Corp *w Exp 09/30/202	0.0	$0		690k	0.00	View chart

Past Filings by Finepoint Capital

SEC 13F filings are viewable for Finepoint Capital going back to 2014

Finepoint Capital 2023 Q3 filed Nov. 13, 2023
Finepoint Capital 2023 Q2 filed Aug. 11, 2023
Finepoint Capital 2023 Q1 filed May 12, 2023
Finepoint Capital 2022 Q4 filed Feb. 13, 2023
Finepoint Capital 2022 Q3 filed Nov. 10, 2022
Finepoint Capital 2022 Q2 filed Aug. 12, 2022
Finepoint Capital 2022 Q1 filed May 13, 2022
Finepoint Capital 2021 Q4 filed Feb. 11, 2022
Finepoint Capital 2021 Q3 filed Nov. 12, 2021
Finepoint Capital 2021 Q2 filed Aug. 13, 2021
Finepoint Capital 2021 Q1 filed May 14, 2021
Finepoint Capital 2020 Q4 filed Feb. 12, 2021
Finepoint Capital 2020 Q3 filed Nov. 13, 2020
Finepoint Capital 2020 Q2 filed Aug. 13, 2020
Finepoint Capital 2020 Q1 filed May 13, 2020
Finepoint Capital 2019 Q4 filed Feb. 13, 2020

View all past filings

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z